Aptevo Therapeutics (APVO) vs Kairos Pharma (KAPA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Aptevo Therapeutics is the larger company by market cap ($3.3 million vs $3.2 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | APVO | KAPA |
|---|---|---|
| Share price | $1.80 | $0.94 |
| Market cap | $3.26M | $3.18M |
| 1-day change | 0.00% | -2.04% |
| P/E ratio (TTM) | 0.03 | — |
| EPS (TTM) | $66.96 | $-1.96 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $31.14 | $9.24 |
| 52-week low | $1.37 | $0.848 |
| Distance from 52-week high | -94.22% | -89.83% |
| Analyst consensus | none | none |
| Avg. price target upside | +1316.67% | +5113.04% |
| Average volume | 91.51K | 602.89K |
| Shares outstanding | 1.81M | 3.39M |
| Employees | 33 | 1 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Aptevo Therapeutics
APVO stock →Aptevo Therapeutics Inc., a clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. The company develops its products using ADAPTIR and ADAPTIR-FLEX platforms to generate monospecific, bispecific, and multi-specific antibody candidates capable of enhancing the human immune system against cancer cells.
Health Care · Biotechnology: Pharmaceutical Preparations · 33 employees
About Kairos Pharma
KAPA stock →Kairos Pharma, Ltd., a clinical-stage biopharmaceutical company, develops immunotherapy and cell therapies for the treatment of cancer. The company offers therapeutics, including antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma.
Health Care · Biotechnology: Pharmaceutical Preparations · 1 employees
APVO vs KAPA FAQ
Which is bigger, Aptevo Therapeutics or Kairos Pharma?
Aptevo Therapeutics (APVO) is larger, with a market capitalization of $3.26M compared with $3.18M for Kairos Pharma (KAPA).
Are Aptevo Therapeutics and Kairos Pharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.